Srinivas Nalamachu
Physical Medicine & Rehabilitation · Overland Park, KSNPI 1497716914
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $297,860 of the $344,296 with a category attached, or 86.5%. Scilex Pharmaceuticals Inc. accounts for 90.6% of it on its own, with 36 other manufacturers making up the rest. 2025 is the largest year on record at $168,539, more than ten times the $15,430 reported in 2019. Among physical medicine & rehabilitation clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 227 payments — averaging $1516.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Scilex Pharmaceuticals Inc.$312K
- Daiichi Sankyo Inc.$13K
- Tonix Medicines, Inc.$5K
- Amgen$3K
- Redhill Biopharma Inc.$3K
- Pfizer$2K
- plus $7K from 31 others
Across 42 payments — averaging $8776.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Nevro Corp.$342K
- Pfizer$8K
- Vertex$7K
- Teva Pharmaceuticals USA, Inc.$6K
- Eli Lilly$3K
- Novartis$2K
What the payments were for
- Consulting fees$297,86087%
- Speaking & faculty fees$21,3756%
- Travel & lodging$19,3216%
- Food & beverage$5,7342%
- Education$50%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Scilex Pharmaceuticals Inc. | 78 | $312,018 |
| Daiichi Sankyo Inc. | 12 | $12,515 |
| Tonix Medicines, Inc. | 5 | $5,450 |
| Amgen | 5 | $3,336 |
| Redhill Biopharma Inc. | 4 | $2,617 |
| Pfizer | 18 | $1,664 |
| Biodelivery Sciences International, Inc. | 4 | $1,538 |
| Shionogi Inc | 2 | $1,438 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 16 | $975 |
| Vertex | 1 | $375 |
| GRT US Holding, Inc. | 14 | $348 |
| Acadia Pharmaceuticals Inc | 4 | $274 |
| Collegium Pharmaceutical, Inc. | 13 | $255 |
| Lundbeck LLC | 3 | $170 |
| Boston Scientific | 2 | $146 |
| Neurocrine Biosciences, Inc. | 1 | $127 |
| Nevro Corp. | 1 | $99 |
| Tris Pharma Inc | 1 | $98 |
| Saluda Medical Americas, Inc. | 1 | $98 |
| Tersera Therapeutics LLC | 4 | $92 |
| Novartis | 5 | $75 |
| Lilly USA, LLC | 5 | $71 |
| Sentynl Therapeutics, Inc. | 5 | $62 |
| Heron Therapeutics, Inc. | 1 | $57 |
| Zyla Life Sciences, Inc. | 4 | $54 |
| Pacira Therapeutics, Inc. | 1 | $50 |
| Lexicon Pharmaceuticals, Inc. | 1 | $48 |
| AbbVie | 3 | $42 |
| Electronic Waveform Lab, Inc. | 2 | $38 |
| Indivior Inc. | 2 | $37 |
| Upsher-smith Laboratories LLC | 2 | $31 |
| MDD US Operations, LLC | 2 | $30 |
| Merck | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| AstraZeneca | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
| Fidia Pharma USA Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$344,296 in reported general payments places this provider in the 95th percentile of 80 physical medicine & rehabilitation providers in Kansas.
See all physical medicine & rehabilitation providers in Kansas →
Other physical medicine & rehabilitation in Overland Park
- Atul PatelOverland Park$643K
- Renjini ChandraOverland Park$8K
- Lauren NeumanOverland Park$3K
- Deborah RugglesOverland Park$1K
- Anthony BurgessOverland Park$990
- Apurva ChopadeOverland Park$616
- Andrew HiettOverland Park$475
- Cole KretchmarOverland Park$233
- Cherie SutherOverland Park$130
- Joshua SteinOverland Park$101
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.